Zenosense, Inc.
ZENO · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.02 | 0.06 | 3.87 |
| FCF Yield | -13.83% | 0.00% | 0.00% | -1.93% |
| EV / EBITDA | -48.75 | -6.16 | -11.28 | -10.81 |
| Quality | ||||
| ROIC | 1.82% | 24.47% | 33.65% | 34.28% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.04 | – | – | 0.14 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | 0.00% | 0.00% | 100.00% | 20.93% |
| Safety | ||||
| Net Debt / EBITDA | -41.52 | -3.35 | -3.35 | -0.73 |
| Interest Coverage | -0.04 | -0.54 | -0.54 | -0.57 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |